The Food and Drug Administration released results this week from the largest chemical contaminant testing program ever conducted on infant formula sold in the United States. More than 300 samples were tested across powders, ready-to-feed liquids, and concentrated liquids. The testing generated over 120,000 data points. The contaminants tested for included lead, mercury, cadmium, arsenic, PFAS, phthalates, glyphosate, and glufosinate.
The headline from the FDA was reassuring: an overwhelming majority of samples had undetectable or very low levels of contaminants. The infant formula supply is safe. That is the official message, and there is real data behind it.
The more important sentence in the press release was quieter: the FDA is following up with additional testing because some samples “initiated additional follow-up actions.” The agency also acknowledged that it has not yet established formal action levels — the regulatory thresholds that define how much of a given contaminant is too much — for contaminants in infant formula. That means this is the first time anyone has systematically looked, and the regulatory framework for what to do about what they find is still being built.
Secretary Kennedy, in announcing the results, said something that deserves to be quoted directly: “even small exposures matter for newborns.” That sentence exists in tension with the “the supply is safe” message in the same press release. Both things can be true. The supply is not at levels that trigger existing safety standards. And small exposures in the first months of life, when neurological development is at its most rapid and vulnerable, are not the same as small exposures at any other time.
Glyphosate and PFAS are worth a moment’s attention specifically. Glyphosate is the active ingredient in Roundup and the most widely used herbicide in American agriculture. It enters the food supply through crops, water, and soil. PFAS — per- and polyfluoroalkyl substances — are the “forever chemicals” that have accumulated in water systems, soil, and human tissue across the country because they do not break down in the environment. Both were found in some samples at some level. The FDA says those levels were low. The honest caveat is that the long-term developmental effects of low-level combined exposures in infants have not been comprehensively studied.
Operation Stork Speed, the FDA initiative that produced this testing, represents a genuine shift in how the agency approaches infant formula oversight. Kennedy will meet with the chief executives of major formula manufacturers in May to discuss contaminant reduction and supply chain transparency. Both of those conversations are overdue.
For parents who depend on formula — and millions of families do, for reasons that range from medical necessity to circumstance — the practical takeaway is not panic. It is awareness. The data now exists in a way it did not before, the FDA has committed to publishing follow-up results, and the standard of accountability for what goes into the first food many American children consume has been formally raised. Whether the regulatory framework catches up to the testing is the question that will define what this announcement actually meant.
The full product-level testing results are available at fda.gov. The Detox America program covers environmental toxin exposure, PFAS, and what the evidence shows about reducing body burden — for anyone who wants to go deeper than what the press release offers.
Independent reporting. Real stories. No agenda but truth.
